Dr. Bashir Al Hussein Al Awamlh is a Urologic Oncologist and Assistant Professor of Urology at Weill Cornell Medicine and NewYork-Presbyterian Hospital. He completed his urology residency at NewYork-Presbyterian/Weill Cornell Medical Center, followed by a Society of Urologic Oncology (SUO) fellowship at Vanderbilt University Medical Center. He also holds a Master of Public Health in Epidemiology from Vanderbilt University and earned his medical degree from the University of Jordan in Amman.

Dr. Al Hussein is a urologic cancer surgeon who specializes in the diagnosis and management of genitourinary malignancies, including prostate, kidney, bladder, testicular, and penile cancers. He provides comprehensive cancer care using both robotic and open surgical approaches, tailored to the complexity and stage of each patient's disease. His expertise includes minimally invasive robotic procedures—such as radical prostatectomy, partial nephrectomy, and cystectomy—as well as complex open operations for advanced or anatomically challenging tumors.

Dr. Al Hussein's research focuses on applying epidemiologic methods to improve the quality of cancer care, with an emphasis on decision-making, survivorship, and health literacy. His work has been published in leading journals, including The Journal of the American Medical Association (JAMA), The New England Journal of Medicine, and JAMA Internal Medicine. He is a recipient of the American Urological Association Research Scholar Award and serves as Director of the Adult Urology Clinic within the Department of Urology at Weill Cornell Medicine.

News

Most Men With Low-Risk Prostate Cancers Now Forgo Immediate Surgery

https://www.usnews.com/news/health-news/articles/2023-04-04/most-men-with-low-risk-prostate-cancers-now-forgo-immediate-surgery

Decade-Long Study Offers Guidance on Treatments for Prostate Cancer

https://www.usnews.com/news/health-news/articles/2024-01-24/decade-long-study-offers-guidance-on-treatments-for-prostate-cancer

Insights into adverse effects may help guide prostate cancer treatment decision-making

https://www.healio.com/news/hematology-oncology/20240227/insights-into-adverse-effects-may-help-guide-prostate-cancer-treatment-decisionmaking

Comparing Side Effects of Prostate Cancer Treatments

https://newsinhealth.nih.gov/2024/04/comparing-side-effects-prostate-cancer-treatments

More U.S. Prostate Cancer Patients Choosing Active Surveillance

https://www.newswise.com/articles/more-u-s-prostate-cancer-patients-choosing-active-surveillance2

More Men Choose Active Surveillance for Prostate Cancer

https://www.newsmax.com/health/health-news/prostate-cancer-low-risk/2023/04/05/id/1115105/

More men with prostate cancer opting for active surveillance

https://www.healio.com/news/hematology-oncology/20230403/more-men-with-prostate-cancer-opting-for-active-surveillance

https://www.usatoday.com/story/news/health/2024/01/24/prostate-cancer-treatment-study/72336323007/

10-year study evaluates prostate cancer treatments, side effects

https://www.msn.com/en-us/health/other/10-year-study-evaluates-prostate-cancer-treatments-side-effects/ar-BB1hc5v7

Understanding Functional Outcomes in Prostate Cancer

https://www.medscape.com/s/viewarticle/understanding-functional-outcomes-prostate-cancer-2024a10001t2?src=rss

Treatment Adverse Events Vary With Favorable, Unfavorable Prognosis in Prostate Cancer

https://www.physiciansweekly.com/treatment-adverse-events-vary-with-favorable-unfavorable-prognosis-in-prostate-cancer/

Cory Booker didn't go to the bathroom for 25 hours. Is that … OK?

https://www.theguardian.com/wellness/2025/apr/03/how-long-without-peeing-is-bad